🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06845631
Recruiting Not applicable

Retrospective-Prospective PNS Study

NCT06845631 · tracked via the Priya Life Science USA tracker
Sponsor
Curonix LLC
Phase
Not applicable
Started
2024-07-01
Last updated
2025-02-25

Condition(s) studied

Chronic Pain

Investigational drug(s) / intervention(s)

PNS device, observational study, no intervention during study

PNS device, observational study, no intervention during study: PNS device, observational study, no intervention during study

Study summary

This is a retrospective-prospective study in which 40 patients have received a permanent Freedom PNS System. Subjects presented with chronic, intractable pain of peripheral nerve origin refractory to standard medical and/or surgical treatment.

A retrospective chart review will be conducted to assess baseline and follow-up parameters in patients who have received a permanent implant with the Freedom PNS system for at least 12 months. Missing data might be collected after informed consent.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: A. Subject is ≥ 18 years of age at time permanent implant; B. Subject has been implanted with the Freedom PNS system; C. Subject is willing to attend visit as scheduled, and comply with the study requirements (if prospective); D. Patient is capable of giving informed consent. Exclusion Criteria: A. Subject is currently enrolled in or plans to enroll in any concurrent drug and/or device study while participating in this study (if prospective); B. Any additional active implanted devices for the treatment of chronic pain in addition to the Freedom PNS system.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Metrohealth System Cleveland Ohio Recruiting

More Curonix LLC trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06845631 on ClinicalTrials.gov ↗ ← All trials in the USA